Related Experiment Video

Updated: Mar 19, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
08:29

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer

Published on: November 1, 2019

7.7K

Targeting the sumoylation pathway in cancer stem cells

Maria V Bogachek1, James P De Andrade1, Ronald J Weigel2

  • 1Department of Surgery; University of Iowa ; Iowa City, IA USA.

Molecular & Cellular Oncology
|June 17, 2016
PubMed

Insights

Inhibition of the sumoylation pathway effectively eliminates cancer stem cells (CSCs) and reduces tumor growth in basal breast cancer models. This pathway presents a promising new therapeutic target for this cancer type.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cancer stem cells (CSCs) are crucial for tumor initiation and progression.
  • Basal breast cancer is an aggressive subtype with limited treatment options.

Purpose of the Study:

  • To investigate the role of the sumoylation pathway in cancer stem cells.
  • To evaluate the therapeutic potential of targeting sumoylation in basal breast cancer.

Main Methods:

  • Inhibition of the sumoylation pathway.
  • Assessment of cancer stem cell populations.
  • Xenograft models of basal breast cancer.

Main Results:

  • Sumoylation pathway inhibition led to the clearance of cancer stem cells.
  • Targeting sumoylation repressed the outgrowth of basal breast cancer xenografts.

Conclusions:

  • The sumoylation pathway is critical for maintaining cancer stem cell populations.
  • Targeting the sumoylation pathway represents a novel and effective treatment strategy for basal breast cancer.
Keywords:
CD44SUMOTFAP2Abasal breast cancercancer stem cellsepithelial-mesenchymal transitionsumoylation

More Related Videos

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.9K
Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics11:28

Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics

Published on: May 11, 2016

9.1K

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K